Fukuoka, Japan

Ken Kanematsu

This inventor holds 1 USPTO granted patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ken Kanematsu. Retrieved from https://idiyas.com/inventor/ken-kanematsu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ken Kanematsu: Innovator in Morphine Derivatives

Introduction

Ken Kanematsu is a notable inventor based in Fukuoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel morphine derivatives. His work has implications for pain management and the pharmaceutical industry.

Latest Patents

Ken Kanematsu holds a patent for a unique compound titled "6 .beta.-Thiomorphine derivatives." This morphine derivative is represented by a specific general formula, wherein R.sub.1 can be a hydrogen atom, a lower alkyl group, or a lower alkanoyl group. This innovation showcases his expertise in medicinal chemistry and drug development.

Career Highlights

Throughout his career, Kanematsu has been associated with Chugai Seiyaku Kabushiki Kaisha, a prominent pharmaceutical company. His work there has allowed him to focus on research and development, contributing to advancements in pain relief medications.

Collaborations

Ken Kanematsu has collaborated with notable colleagues, including Mitsutaka Yoshida and Issei Takayanagi. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Ken Kanematsu's contributions to the field of morphine derivatives highlight his role as an important inventor in the pharmaceutical industry. His work continues to influence pain management solutions and showcases the impact of innovative research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…